Genetic characterization of variants of HPV‑16, HPV‑18 and HPV‑52 circulating in Italy among general and high‑risk populations.


Journal

Molecular medicine reports
ISSN: 1791-3004
Titre abrégé: Mol Med Rep
Pays: Greece
ID NLM: 101475259

Informations de publication

Date de publication:
02 2020
Historique:
received: 28 02 2019
accepted: 30 08 2019
pubmed: 4 12 2019
medline: 28 8 2020
entrez: 3 12 2019
Statut: ppublish

Résumé

Viral factors, such as high‑risk human papillomavirus variants, can increase the risk of viral persistence and influence the progression to cancer. In the present study, the long control region (LCR) of human papillomavirus (HPV)‑16 and HPV‑52, and the L1 region of HPV‑16 and HPV‑18, identified from subjects belonging to both general and high‑risk populations (migrants, HIV+ subjects and adolescent/young people) residing in Italy, were characterized using molecular and phylogenetic techniques. To the best of our knowledge, this is the first Italian study to analyze a large number of sequences (n=458) and report phylogenetic data on the HPV‑52 variants. The phylogenetic analysis showed that 90% of the LCR variants of HPV‑16 and HPV‑52 clustered within lineage A (European lineage) and only sequences identified from subjects belonging to high‑risk populations fell into the non‑European lineages. Analysis of the LCRs revealed a high genomic diversity with a large number of changes. Several mutations in the binding sites for viral and cellular transcription factors characterized the HPV‑16 LCR variants belonging to the African lineages B and C, were observed in subjects with cytological abnormalities (high squamous intraepithelial lesions). The HPV‑16 and HPV‑18 L1 molecular characterization identified 30% of changes in the immune‑dominant epitope loops. These data give a clear picture of the situation in Italy, and a starting point for understanding the molecular pathogenesis and developing molecular diagnostics for HPV, vaccines and other therapeutic approaches in order to control and/or eliminate virus‑induced diseases.

Identifiants

pubmed: 31789404
doi: 10.3892/mmr.2019.10847
doi:

Substances chimiques

DNA, Viral 0
Epitopes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

894-902

Auteurs

Elena Rosanna Frati (ER)

Department of Biomedical Sciences for Health, University of Milan, I‑20133 Milan, Italy.

Silvia Bianchi (S)

Department of Biomedical Sciences for Health, University of Milan, I‑20133 Milan, Italy.

Antonella Amendola (A)

Department of Biomedical Sciences for Health, University of Milan, I‑20133 Milan, Italy.

Daniela Colzani (D)

Department of Biomedical Sciences for Health, University of Milan, I‑20133 Milan, Italy.

Fabio Petrelli (F)

School of Medicinal and Health Products Sciences, University of Camerino, I‑62032 Camerino, Italy.

Gianguglielmo Zehender (G)

Coordinated Research Centre 'EpiSoMI', University of Milan, I‑20133 Milan, Italy.

Elisabetta Tanzi (E)

Department of Biomedical Sciences for Health, University of Milan, I‑20133 Milan, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH